felin
immunodefici
viru
fiv
lentiviru
worldwid
distribut
infect
retroviru
lead
immunodefici
domest
cat
pathogen
potenti
wild
felid
less
well
known
due
lack
proofread
capac
revers
transcriptas
high
error
rate
replic
low
replic
fidel
current
five
major
clade
subtyp
fiv
describ
base
phylogenet
analys
variabl
region
fiv
env
gene
well
portion
gag
gene
genet
intraclad
divers
genet
distanc
differ
fiv
clade
found
recent
strain
tent
assign
new
clade
brazil
turkey
usa
portug
new
zealand
two
latter
cluster
exhibit
new
subtyp
f
unzenv
fiv
clade
strain
found
worldwid
clade
show
vari
geograph
preval
separ
evolut
clade
geograph
distinct
area
introduct
area
propos
preval
fiv
clade
found
europ
b
clade
predomin
northern
europ
germani
benelux
uk
clade
b
occur
frequent
southern
europ
portug
itali
austria
croatia
turkey
north
america
fiv
clade
b
c
describ
south
america
clade
b
e
report
clade
b
e
predomin
clade
e
describ
geograph
area
far
limit
inform
fiv
strain
clade
avail
asia
clade
c
seem
common
taiwan
vietnam
subtyp
describ
china
subtyp
b
c
report
japan
b
preval
subtyp
clade
found
japan
vietnam
clade
b
distribut
australia
c
unzenv
found
new
zealand
interestingli
cat
infect
concurr
sever
fiv
strain
overal
geograph
restrict
evolut
subtyp
e
f
increas
import
domest
cat
possibl
coinfect
fiv
strain
one
subtyp
might
result
intersubtyp
recombin
chang
local
prevail
fiv
clade
laboratori
diagnosi
fiv
infect
primarili
reli
detect
antibodi
fiv
infect
cat
sinc
fiv
load
peripher
blood
usual
low
antibodi
fiv
almost
univers
featur
fivinfect
cat
furthermor
genet
divers
known
lead
challeng
molecular
diagnosi
infect
recombin
viral
strain
emerg
antigen
variant
might
also
result
antibodi
longer
recogn
common
diagnost
test
practition
diagnost
pointofcar
test
poct
quickli
detect
antibodi
method
choic
antibodi
fiv
transmembran
protein
tm
reliabl
term
initi
appear
post
infect
durat
detect
blood
therefor
mani
poct
enzymelink
immunoassay
elisa
use
diagnost
laboratori
use
fivtm
captur
antigen
capsid
protein
also
ad
test
detect
fiv
antibodi
western
blot
wb
consid
gold
standard
use
confirm
fiv
diagnosi
case
ambigu
poct
elisa
result
addit
wb
recommend
confirm
elisa
poctposit
result
countri
low
fiv
preval
sinc
posit
predict
valu
posit
elisa
poct
result
low
circumst
mani
year
sampl
cat
suspect
fiv
infect
ambigu
posit
poct
result
sent
laboratori
confirm
fiv
diagnosi
use
western
blot
furthermor
receiv
sampl
primari
fiv
screen
purpos
fivtm
elisa
routin
test
sampl
would
sporad
found
neg
fivtm
elisa
posit
wb
phenomenon
alreadi
describ
develop
fivtm
elisa
found
four
test
sampl
cat
live
outsid
switzerland
hypothes
number
fiv
infect
undetect
fivtm
elisa
poct
increas
year
due
increas
number
cat
travel
import
histori
thu
introduc
novel
fiv
isol
sampl
popul
thu
aim
studi
systemat
test
sampl
sent
laboratori
two
decad
use
fivtm
elisa
well
wb
gold
standard
fiv
test
case
discrep
result
suffici
sampl
volum
two
commerci
avail
poct
snaptm
combo
plu
felv
agfiv
ab
idexx
laboratori
westbrook
usa
witnessr
fiv
zoeti
switzerland
rtpcr
assay
ftvet
felin
anaemia
fast
track
diagnost
eschsuralzett
luxembourg
perform
addit
attempt
made
sequenc
rtpcrposit
sampl
studi
includ
total
sampl
includ
sampl
fivinfect
cat
base
wb
analysi
felin
plasma
serum
sampl
submit
clinic
laboratori
vetsuiss
faculti
univers
zurich
switzerland
end
begin
avail
studi
sampl
taken
veterinari
practition
part
diagnost
workup
sent
laboratori
routin
diagnost
purpos
leftov
sampl
use
addit
blood
volum
collect
current
studi
ethic
approv
necessari
studi
complianc
swiss
regul
fivtm
elisa
perform
previous
describ
modif
felin
serum
sampl
dilut
test
duplic
posit
neg
control
run
plate
posit
control
pool
sera
experiment
fivinfect
cat
use
everi
run
neg
control
consist
heatinactiv
bovin
serum
plate
incub
one
hour
wash
three
time
horseradish
peroxidaselabel
goat
anticat
immunoglobulin
g
hl
jackson
immunoresearch
laboratori
west
grove
pa
usa
use
conjug
dilut
absorb
measur
elisa
plate
reader
spectramax
plu
bucher
biotec
ag
basel
switzerland
nm
optic
densiti
od
valu
cat
serum
sampl
express
percentag
valu
obtain
posit
control
sera
result
comparison
posit
control
classifi
posit
wherea
classifi
neg
classifi
ambigu
wb
conduct
previous
describ
use
ng
gradientpurifi
fiv
propag
felin
specifiedpathogen
free
lymphocyt
cultur
presenc
recombin
felin
serum
sampl
dilut
incub
wb
strip
overnight
rocker
platform
room
temperatur
peroxidaselabel
goat
anticat
immunoglobulin
g
hl
conjug
jackson
immunoresearch
laboratori
dilut
incub
two
hour
wash
step
substrat
hrp
color
develop
biorad
laboratori
hercul
ca
usa
ad
posit
serum
fivposit
cat
neg
control
buffer
run
blot
wb
consid
posit
two
band
molecular
weight
dalton
respect
recogniz
blot
strip
band
absent
sampl
judg
wbneg
sampl
yield
one
band
either
judg
inconclus
wbposit
neg
result
inconclus
result
includ
statist
analysi
depend
remain
sampl
volum
elisaneg
wbposit
sampl
test
use
two
differ
pointofcar
test
witnessr
fiv
zoeti
switzerland
andor
snaptm
felv
agfiv
ab
combo
plu
idexx
laboratori
westbrook
usa
kit
materi
sampl
allow
warm
room
temperatur
perform
test
snaptm
use
directli
witnessr
accord
manufactur
recommend
read
result
perform
min
activ
test
elisafals
neg
wbposit
sampl
underw
one
poct
test
enough
remain
volum
addit
test
n
analyz
rtpcr
addit
elisa
falseneg
sampl
littl
volum
combin
poct
rtpcr
analys
n
underw
rtpcr
increas
chanc
viral
rna
confirm
least
one
discord
sampl
moreov
sampl
fivinfect
cat
elisa
wbposit
includ
control
total
nucleic
acid
extract
edta
anticoagul
blood
use
magnar
pure
lcr
total
nucleic
acid
isol
kit
roch
diagnost
gmbh
mannheim
germani
rna
anticoagul
plasma
serum
qiaampr
viral
rna
kit
qiagen
gmbh
hilden
germani
notabl
prior
nucleic
acid
extract
sampl
undergon
unknown
number
cycl
store
year
neg
control
consist
phosphat
buffer
salin
prepar
extract
batch
monitor
crosscontamin
nucleic
acid
sampl
analyz
realtim
rtpcr
allow
amplif
variou
fiv
isol
clade
b
describ
previous
follow
modif
final
reaction
volum
contain
nm
primer
nm
fluorogen
probe
rt
qpcr
mastermix
master
mix
contain
u
euroscript
revers
transcriptas
u
rnase
inhibitor
one
step
rt
qpcr
mastermix
plu
low
rox
eurogentec
headquart
sera
belgium
cycl
condit
follow
min
revers
transcript
follow
initi
denatur
min
amplif
cycl
min
previous
describ
use
fast
realtim
pcr
system
thermofish
scientif
zug
ch
second
realtim
rtpcr
perform
accord
modifi
version
method
use
wang
et
al
use
nm
upstream
fivgagupstr
atg
ggg
aay
gga
cag
ggg
cga
downstream
fivgagdownstr
tct
ggt
atr
tca
cca
ggt
tct
cgt
cct
primer
nm
fluorogen
probe
cca
twa
ara
gat
gya
gta
atg
ttg
ctg
tag
rnasinr
plu
promega
madison
wi
usa
rt
qpcr
reaction
mix
superscripttm
iii
rtplatinumr
taq
mixtur
rox
superscripttm
iii
platinumtm
onestep
qrtpcr
kit
thermofish
scientif
carlsbad
ca
usa
final
volum
reaction
mix
underw
revers
transcript
min
denatur
activ
min
cycl
addit
nucleic
acid
sampl
test
use
commerci
avail
realtim
rtpcr
kit
ftvet
felin
anaemia
fast
track
diagnost
eschsuralzett
luxembourg
final
seminest
rtpcr
perform
amplifi
bplong
sequenc
fiv
clade
b
gag
gene
use
primer
previous
describ
concentr
nm
primer
first
round
primer
second
round
final
reaction
volum
round
reaction
mix
superscriptr
polymeras
superscriptr
iii
onestep
rtpcr
platinumr
taq
kit
thermofish
scientif
rnasinr
plu
promega
use
first
round
wherea
buffer
taq
dna
polymeras
sigmaaldrich
st
loui
mo
usa
dntp
thermofish
scientif
vilniu
lithuania
use
second
round
briefli
revers
transcript
step
perform
min
follow
first
round
pcr
consist
min
cycl
min
min
final
step
min
second
round
first
round
pcr
product
use
follow
cycl
condit
five
minut
follow
cycl
min
final
elong
step
min
pcr
product
second
round
pcr
analyz
agaros
gel
electrophoresi
band
expect
length
purifi
qiaquickr
gel
extract
kit
qiagen
gmbh
submit
sequenc
microsynth
ag
balgach
switzerland
sequenc
edit
assembl
use
geneiousr
softwar
biomatt
ltd
auckland
new
zealand
use
basic
local
align
search
tool
ncbi
http
blastncbinlmnihgovblastcgi
aim
find
similar
isol
sequenc
publish
fiv
sequenc
wb
consid
gold
standard
accur
identifi
fiv
posit
neg
sampl
diagnost
sensit
specif
effici
fivtm
elisa
calcul
data
compil
microsoft
excel
analyz
use
graphpad
prism
version
graphpad
prism
softwar
la
jolla
ca
usa
frequenc
compar
use
fisher
exact
test
pf
age
cat
differ
group
compar
use
utest
pmwu
pvalu
consid
statist
signific
cat
includ
studi
age
known
cat
median
age
year
tabl
sex
cat
known
intact
male
castrat
male
respect
intact
spay
femal
respect
tabl
sampl
obtain
switzerland
germani
franc
austria
finland
itali
nine
sampl
countri
origin
unknown
result
fiv
wb
analys
use
gold
standard
determin
fiv
statu
cat
test
sampl
fiv
wbposit
fiv
wbneg
inconclus
result
produc
one
band
wb
tabl
wbposit
cat
age
known
median
age
wbposit
cat
year
tabl
seventeen
cat
year
old
younger
fivposit
result
cat
could
result
matern
antibodi
sex
wbposit
cat
known
posit
sampl
origin
intact
male
neuter
male
intact
femal
spay
femal
tabl
wbposit
sampl
came
switzerland
n
germani
n
sampl
sent
countri
tabl
wbneg
cat
age
known
cat
median
age
wbneg
cat
year
tabl
inform
sex
avail
cat
intact
male
neuter
male
intact
femal
spay
femal
cat
wbneg
sampl
sent
switzerland
n
germani
n
franc
n
austria
n
finland
n
itali
n
three
sampl
origin
unknown
sampl
includ
studi
collect
randomli
origin
mainli
cat
clinic
suspect
fiv
infect
nonetheless
basic
descript
analys
perform
fiv
wbposit
cat
significantli
like
male
either
intact
castrat
fiv
wbneg
cat
pf
tabl
median
age
differ
significantli
wbposit
median
age
year
wbneg
cat
median
age
year
pmwu
fiv
wbposit
sampl
origin
less
frequent
switzerland
wbneg
sampl
pf
wbneg
sampl
fivtm
elisaneg
show
ambigu
result
accord
elisa
tabl
recommend
ambigu
fivtm
elisa
result
directli
retest
wb
therefor
pose
immin
problem
term
diagnosi
fiv
infect
fals
positivefals
neg
analyz
studi
howev
wbneg
sampl
found
falseposit
accord
fivtm
elisa
sampl
fiv
wbposit
also
tm
elisaposit
reveal
ambigu
result
remark
wbposit
sampl
neg
accord
tm
elisa
tabl
diagnost
sensit
true
positivesal
posit
fivtm
elisa
diagnost
specif
true
negativesal
neg
diagnost
effici
correct
testsal
test
overal
cat
falseposit
accord
fivtm
elisa
wbneg
elisaposit
tabl
eight
sampl
suffici
volum
avail
test
also
use
one
poct
two
sampl
test
neg
poct
six
posit
least
one
poct
perform
tabl
three
sampl
poct
could
perform
poctneg
sampl
od
valu
fivtm
elisa
low
posit
rang
accord
definit
posit
posit
control
poctposit
sampl
one
except
od
valu
posit
control
fivtm
elisa
characterist
cat
falseneg
elisa
result
wbposit
elisaneg
summar
tabl
data
cat
given
tabl
sampl
origin
frequent
male
cat
femal
cat
sampl
sent
mainli
switzerland
germani
five
sampl
franc
tabl
median
age
cat
falseneg
elisa
result
year
tabl
lower
cat
fiv
wb
elisaposit
result
year
tabl
minimum
age
two
month
observ
group
oldest
cat
falseneg
elisa
result
year
old
among
wb
elisaposit
cat
year
maximum
age
sever
sampl
year
one
two
falseneg
case
per
year
wbposit
sampl
sent
respect
year
four
discord
case
fourteen
wbposit
sampl
respect
discord
sampl
repres
wbposit
sampl
n
n
n
n
tabl
tabl
sampl
falseneg
elisa
result
wbposit
tm
elisaneg
could
test
least
one
two
poct
witnessr
snaptm
sixti
sampl
enough
sampl
volum
perform
first
poct
witnessr
also
enough
volum
perform
second
poct
snaptm
four
addit
sampl
test
snaptm
test
total
sampl
snaptmtest
witnessr
test
one
sampl
test
clearli
posit
tabl
one
sampl
sampl
id
show
band
regular
read
time
min
pass
clearli
neg
sampl
use
snaptm
test
five
sampl
posit
neg
tabl
sampl
test
posit
late
posit
witnessr
test
also
posit
snaptm
test
snaptm
test
detect
two
addit
sampl
neg
witnessr
test
one
test
witnessr
test
fals
elisaneg
sampl
low
od
accord
fivtm
elisa
one
sampl
doubl
posit
two
poct
one
sampl
test
snaptm
test
od
respect
bare
cutoff
valu
ambigu
sampl
tabl
addit
sampl
neg
poct
show
result
sampl
id
cutoff
valu
fivtm
elisa
two
snaptmwitnessr
doubl
posit
sampl
posit
sampl
test
snaptm
test
sent
franc
switzerland
two
sampl
detect
sole
snaptm
test
germani
switzerland
enough
sampl
volum
remain
discord
sampl
nucleic
acid
extract
perform
fiv
rtpcr
six
sampl
test
use
rtpcr
poct
perform
remain
materi
suffici
poct
rtpcr
increas
chanc
rtpcr
confirm
subsequ
sequenc
discord
sampl
decid
use
rtpcr
low
volum
sampl
none
sampl
test
posit
previous
describ
fiv
realtim
rtpcr
allow
amplif
variou
fiv
isol
clade
b
modif
rtpcr
method
describ
wang
three
sampl
test
weakli
posit
ctvalu
accord
commerci
realtim
rtpcr
kit
ftvet
felin
anaemia
tabl
seminest
rtpcr
reveal
weak
band
one
cat
could
sequenc
five
elisa
wbposit
sampl
also
analyz
control
use
rtpcr
five
sampl
high
od
valu
tm
elisa
posit
poct
five
sampl
posit
accord
least
two
differ
rtpcr
assay
tabl
blast
search
sequenc
demonstr
high
similar
deposit
sequenc
subtyp
b
found
sampl
inconclus
wb
result
tabl
sampl
major
show
antibodi
band
sampl
elisaposit
od
valu
rang
posit
control
test
elisaneg
six
ambigu
result
fivtm
elisa
tabl
anim
inconclus
wb
result
recommend
retest
two
three
month
later
present
studi
investig
hypothesi
number
fiv
infect
domest
cat
undetect
fivtm
elisa
fiv
poct
screen
assay
increas
year
sporad
identifi
felin
plasma
serum
sampl
posit
accord
confirmatori
fiv
wb
test
neg
accord
fivtm
elisa
screen
assay
phenomenon
alreadi
describ
develop
fivtm
elisa
concern
four
test
sampl
origin
cat
live
outsid
switzerland
assum
number
discord
sampl
could
potenti
risen
due
increas
number
cat
travel
import
histori
might
result
introduct
novel
fiv
isol
sampl
popul
routin
diagnost
case
discord
result
confirm
veterinarian
owner
cat
import
investig
hypothesi
systemat
retest
avail
felin
plasma
serum
sampl
submit
laboratori
last
two
decad
fiv
diagnosi
confirm
use
fivtm
elisa
wb
consid
gold
standard
confirm
method
result
studi
demonstr
increas
percentag
cat
central
europ
test
fivposit
wb
fiv
infect
cat
unrecogn
fivtm
elisa
well
fiv
poct
earlier
studi
mention
fivtm
elisa
use
herein
high
diagnost
sensit
specif
respect
use
wb
gold
standard
fiv
wbposit
sampl
neg
accord
tm
elisa
compar
fiv
wbposit
sampl
collect
august
februari
analyz
current
studi
result
found
indic
reduc
diagnost
sensit
fivtm
elisa
compar
attempt
corrobor
result
regard
reduc
diagnost
sensit
fivtm
elisa
also
use
two
poct
sampl
ampl
remain
sampl
volum
remark
two
poct
recogn
mani
discord
sampl
observ
seriou
diagnost
implic
sinc
fivtm
elisa
well
fiv
poct
use
screen
assay
fiv
infect
highest
sensit
possibl
order
miss
fivinfect
cat
primari
diagnost
screen
step
earlier
studi
four
sampl
discord
result
origin
cat
countri
switzerland
hypothes
fivtm
elisa
might
specif
certain
variant
fiv
assum
routin
test
cat
within
switzerland
absenc
travel
import
histori
cat
sensit
fivtm
elisa
suffici
howev
current
studi
half
cat
discord
result
either
present
swiss
veterinarian
repres
sampl
sent
swiss
laboratori
sent
confirm
laboratori
necessarili
impli
cat
live
switzerland
especi
region
close
border
countri
veterinarian
necessarili
countri
origin
cat
therefor
cat
fiv
infect
unrecogn
fivtm
elisa
might
also
live
abroad
addit
remain
cat
discord
result
origin
mainli
germani
origin
franc
moreov
base
person
commun
cat
owner
knew
least
one
cat
switzerland
discord
fiv
test
result
origin
import
greec
base
earlier
studi
fiv
subtyp
predomin
subtyp
switzerland
germani
southern
europ
turkey
fiv
subtyp
b
common
unabl
analyz
prevail
fiv
subtyp
cat
discord
result
sinc
found
posit
use
variou
rtpcr
assay
serum
plasma
avail
proviru
pcr
requir
anticoagul
whole
blood
could
conduct
test
usual
higher
sensit
fiv
infect
moreov
rtpcr
posit
sampl
viral
rna
load
low
sequenc
viru
nonetheless
data
indic
current
increas
number
fivinfect
cat
switzerland
well
germani
harbor
fiv
isol
induc
antibodi
unrecogn
tm
antigen
use
fivtm
elisa
two
fiv
poct
consid
increas
travel
cat
central
europ
particularli
east
south
north
west
europ
might
concern
european
countri
switzerland
germani
tm
immunodomin
epitop
fiv
induc
earliest
strongest
antibodi
respons
cat
experiment
infect
fiv
although
evolutionari
rate
fiv
rather
slow
compar
lentivirus
seem
depend
viru
strain
infect
stage
shown
prefer
genet
locat
recombin
envelop
env
gene
also
encod
tm
addit
low
fidel
transcript
process
chang
clade
distribut
could
contribut
increas
variabl
protein
appear
new
viral
quasispeci
infect
cat
report
common
viru
transmiss
quasispeci
infect
new
host
undergo
mutat
henc
broaden
genet
divers
import
export
domest
cat
viru
strain
distinct
local
predomin
might
result
chang
viru
strain
distribut
even
spread
region
cluster
subtyp
new
area
take
account
exchang
zoo
interhost
transmiss
wide
rang
behavior
chang
caus
human
expans
nondomest
felid
also
potenti
sourc
therefor
intrasubtyp
recombin
occur
develop
new
subtyp
aris
recombin
strain
distinct
cluster
becom
like
tm
encod
variabl
env
gene
mainli
respons
host
antibodi
respons
mutat
nucleotid
sequenc
lead
structur
chang
result
antibodi
unrecogniz
common
diagnost
test
contrast
capsid
protein
matrix
protein
encod
gag
region
consid
highli
conserv
therefor
antibodi
epitop
present
consist
recogn
suggest
includ
serolog
test
fiv
gag
protein
use
wb
analysi
well
one
includ
poct
snaptm
test
elisabas
test
also
includ
tm
second
poct
includ
studi
witnessr
test
immun
chromatographybas
assay
detect
antibodi
direct
tm
gag
protein
similarli
fivtm
elisa
use
herein
poct
show
low
sensit
present
studi
test
sampl
cat
discord
result
five
test
cat
discord
result
witnessr
test
snaptm
test
posit
poct
result
two
poctposit
result
could
confirm
use
rtpcr
third
poct
doubl
posit
result
found
kitten
month
age
followup
sampl
collect
age
month
kitten
shown
fivneg
wb
thu
initi
poctposit
result
month
like
due
matern
antibodi
rtpcr
result
truli
neg
sinc
viral
rna
present
fourth
snaptm
poctposit
cat
neg
accord
witnessr
poct
test
well
rtpcr
method
employ
age
cat
known
snaptm
signal
weak
presenc
matern
antibodi
fulli
exclud
two
addit
fiv
wbposit
sampl
found
neg
fivtm
elisa
poct
weakli
posit
accord
either
fasttrack
rtpcr
ctvalu
seminest
rtpcr
weak
band
thu
fiv
infect
could
confirm
use
differ
methodolog
detect
viru
instead
antibodi
direct
viru
possibl
complet
exclud
sampl
collect
earli
infect
ampl
titer
antibodi
develop
wb
method
might
somewhat
sensit
kind
earli
infect
howev
usual
see
band
earli
phase
infect
case
two
sampl
overal
sampl
present
studi
show
inconclus
wb
result
band
sampl
might
origin
cat
earli
fiv
infect
order
distinguish
latter
unspecif
reaction
anim
inconclus
result
accord
wb
recommend
retest
two
three
month
later
definit
diagnosi
limit
studi
sampl
store
year
howev
antibodi
sensit
longterm
storag
repeat
cycl
minim
detriment
effect
contrast
viral
rna
sensit
degrad
might
thu
lost
storag
might
contribut
mani
neg
rtpcr
result
discord
sampl
addit
expect
low
viral
load
mani
fivinfect
cat
sequenc
variat
fiv
genom
might
led
lack
recognit
oligonucleotid
use
rtpcr
assay
rtpcrposit
sampl
show
low
viral
load
low
sequenc
long
storag
mani
sampl
repeat
cycl
limit
sampl
volum
uncertainti
concern
steril
sampl
consid
viru
isol
cell
cultur
sinc
discord
sampl
could
test
method
avail
studi
difficult
compar
result
differ
test
howev
overal
snaptm
poct
test
seem
recogn
discord
sampl
witnessr
poct
test
two
snaptm
poctposit
sampl
neg
accord
witnessr
poct
quit
clear
snaptm
poct
identifi
antigen
detect
wbposit
sampl
antibodi
two
highli
conserv
antigen
obvious
present
sampl
sinc
recogn
wb
one
argument
enhanc
sensit
wb
compar
snaptm
test
could
antigen
concentr
per
strip
access
antigen
could
higher
snaptm
test
three
antigen
share
one
reaction
field
inform
exact
antigen
use
differ
test
conform
present
antigen
differ
specif
antigen
differ
test
import
new
virus
mutat
recombin
virus
result
chang
antigen
specif
induc
antibodi
could
contribut
discord
test
result
moreov
sensit
differ
test
could
play
role
obviou
one
sampl
sampl
id
clearli
posit
snaptm
poct
neg
witnessr
poct
normal
read
time
point
min
becam
weakli
posit
thereaft
moreov
one
sampl
sampl
id
cutoff
point
neg
result
fivtm
elisa
sampl
neg
accord
snaptm
witnessr
poct
result
method
except
fivtm
elisa
determin
visual
inspect
posit
sampl
could
fals
interpret
neg
colorimetr
signal
strong
report
sensit
poct
use
herein
differ
depend
respect
geograph
locat
studi
cohort
test
snaptm
test
witnessr
test
decreas
sensit
fivtm
elisa
describ
last
twenti
year
found
base
comparison
studi
investig
sampl
current
studi
influenc
number
sampl
submit
laboratori
awar
veterinarian
fiv
infect
gener
necess
test
fiv
confirm
poct
result
well
geograph
distribut
submit
custom
led
high
number
discord
sampl
discord
sampl
per
year
year
littl
discord
sampl
year
therefor
unabl
determin
whether
decreas
sensit
occur
gradual
time
whether
pose
increas
problem
overal
seem
signific
relev
studi
number
falseneg
sampl
n
greatli
surpass
number
falseposit
sampl
n
issu
falseposit
result
gener
recogn
countri
low
fiv
preval
major
falseposit
sampl
accord
fivtm
elisa
studi
also
falseposit
test
poct
emphas
need
confirm
use
wb
obtain
definit
fiv
diagnosi
final
discord
sampl
could
also
fals
wbposit
chosen
use
wb
gold
standard
detect
fiv
infect
mani
year
countri
fiv
vaccin
avail
case
us
alway
case
europ
wb
accept
gold
standard
fiv
diagnosi
confirm
ambigu
posit
sampl
altern
method
confirm
presenc
absenc
fiv
infect
viru
isol
cell
cultur
howev
method
requir
purif
cultur
fresh
peripher
blood
mononuclear
cell
cat
investig
ideal
cell
uninfect
cat
method
labori
expens
timeconsum
offer
special
laboratori
lymphocytecontain
fresh
whole
blood
sampl
avail
studi
preclud
option
agreement
good
laboratori
practic
alway
run
neg
posit
control
blot
control
falseposit
falseneg
result
discord
sampl
studi
could
confirm
posit
either
use
one
two
poct
employ
studi
rtpcr
even
though
sampl
store
long
time
final
evid
wb
robust
detect
antibodi
varieti
felid
lentivirus
wb
posit
use
wild
felid
speci
lion
cheetah
leopard
geoffroy
cat
reason
quit
confid
wbposit
sampl
cat
true
fiv
infect
conclus
fiv
screen
sole
reli
antibodi
direct
singl
tm
protein
seem
longer
adequ
geograph
area
cat
import
new
virus
must
expect
howev
poct
snaptm
fivfelv
combo
use
addit
fiv
antigen
besid
immunodomin
tm
antigen
recogn
presumpt
fivposit
cat
sinc
elisa
poct
use
screen
purpos
inabl
recogn
increas
number
fivinfect
cat
pose
seriou
problem
current
recommend
confirm
elisa
poct
ambigu
posit
result
countri
low
fiv
preval
sinc
posit
predict
valu
posit
elisa
poct
result
low
circumst
howev
light
result
addit
recommend
cat
high
suspicion
fiv
infect
neg
fiv
screen
test
investig
use
wb
purpos
confirm
exclud
falseneg
result
futur
prospect
studi
aim
character
indepth
fresh
sampl
cat
discord
result
identifi
underli
virus
improv
laboratori
diagnosi
fiv
infect
